Form 4 for FTH Faeth Therapeutics, Inc.
Accepted 2026-06-01 17:21:50 ET · period of report 2026-06-01 · accession 0000897069-26-001299 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-01 17:21 | 2026-06-01 | FTH | Cambrian BioPharma Inc | 10% | S - Sale | $20.02 | -25.0K | 130.1K | -16% | -$500.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | S | D | 24,524 | $20.00 | 130,618 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The prices sold ranged from $20.00 to $21.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2026-06-01 | S | D | 476 | $21.14 | 130,142 | D | — | — |